Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors
2010

ALDH1 Expression in Ovarian Tumors

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Penumatsa Krishna, Edassery Seby L, Barua Animesh, Bradaric Michael J, Luborsky Judith L

Primary Institution: Rush University Medical Center

Hypothesis

Is ALDH1 expression altered in ovarian cancer compared to normal and benign ovarian tissues?

Conclusion

ALDH1 expression is significantly reduced in malignant ovarian tumors compared to normal ovaries and benign tumors.

Supporting Evidence

  • ALDH1 mRNA expression was significantly reduced in malignant tumors compared to normal ovaries and benign tumors.
  • The proportion of ALDH1+ cells was significantly lower in malignant tumors compared to normal ovaries and benign tumors.
  • ALDH1 protein expression was positively correlated with mRNA expression levels.

Takeaway

This study found that a protein called ALDH1 is less present in cancerous ovarian tissues than in normal ones, which might help understand ovarian cancer better.

Methodology

mRNA and protein expression were compared in normal human ovary and serous ovarian tumors using quantitative Reverse-Transcriptase PCR, Western blot, and immunohistochemistry.

Limitations

The study did not examine the relationship of ALDH1 to survival, and the entire tumor was not sampled.

Participant Demographics

Women aged 40 and older with normal ovaries, benign serous ovarian tumors, and malignant serous ovarian tumors.

Statistical Information

P-Value

p < 0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1757-2215-3-28

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication